GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Genetic Requirements of Helicobacter pylori Infection

$458,447
Nina Reda Salama · Fred Hutchinson Cancer Research Center · R01 · FY2018 · AI

Genetic Requirements of Helicobacter pylori Infection

$458,447
Nina Reda Salama · Fred Hutchinson Cancer Research Center · R01 · FY2015 · AI

Genetic Requirements of Helicobacter pylori Infection

$458,447
Nina Reda Salama · Fred Hutchinson Cancer Research Center · R01 · FY2017 · AI

Functional Genomics Core

$458,409
Anthony Haag · Methodist Hospital Research Institute · P01 · FY2022 · AI

Polymeric Agents for the Treatment of Clostridium difficile Infections

$458,393
Shonna M. McBride · Emory University · R33 · FY2020 · AI

Polymeric Agents for the Treatment of Clostridium difficile Infections

$458,393
Shonna M. McBride · Emory University · R33 · FY2019 · AI

Polymeric Agents for the Treatment of Clostridium difficile Infections

$458,393
Shonna M. McBride · Emory University · R33 · FY2018 · AI

Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens

$458,280
Pei Zhou · Duke University · R01 · FY2021 · AI

Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens

$458,280
Pei Zhou · Duke University · R01 · FY2022 · AI

Molecular Basis of Host Parasite Interaction

$458,205
Denise M. Monack · Stanford University · T32 · FY2022 · AI

Antimicrobial evaluation and development

$458,098
Kim Lewis · Northeastern University · P01 · FY2016 · AI

Tear Protein Microbial Regulation

$458,057
Gordon William Laurie · University Of Virginia · R01 · FY2022 · EY

Nanostructure Engineering Is Another Approach Toward Membrane-Active Antimicrobials with Desirable Activity and Selectivity

$457,931
Hongjun Liang · Texas Tech University Health Science Center · · FY2018 · MPS

Mucosal Vaccines against Gonorrhea

$457,807
Ann E. Jerse · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI

A Randomized Controlled Trial of a Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care

$457,805
Larisa Grigoryan · Baylor College Of Medicine · R01 · FY2025 · HS

The role of GraRS in resistance to cationic antimicrobial peptides in S. aureus

$457,767
Ambrose L. Cheung · Dartmouth College · R01 · FY2013 · AI

Impacts of host lipid composition on antimicrobial susceptibilities of Staphylococcus aureus

$457,744
Kelly M. Hines · University Of Georgia · R01 · FY2024 · AI

Improved Therapeutics and Diagnostics for PneumocystisPneumonia

$457,733
Jay K Kolls · Tulane University Of Louisiana · R01 · FY2019 · AI

Chemoenzymatic studies of aminoglycoside-resistance enzymes towards new drugs

$457,682
Sylvie Garneau-Tsodikova · University Of Michigan At Ann Arbor · R01 · FY2011 · AI

Fitness Effects of Beneficial Mutations

$457,450
Gavin J Sherlock · Stanford University · R35 · FY2025 · GM

Fitness Effects of Beneficial Mutations

$457,450
Gavin J Sherlock · Stanford University · R35 · FY2024 · GM

COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core

$457,142
Erika M D'agata · Miriam Hospital · P20 · FY2022 · GM

Mechanism of Cif Virulence: A Bacterial Strategy to Subvert Host-Cell Defenses

$457,132
Dean R Madden · Dartmouth College · R01 · FY2015 · AI

Control of Transcription Initiation

$457,092
Deborah M Hinton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

Development of clinical decision tools for management of diarrhea of children in high and low resource settings

$457,033
Daniel Ted Leung · University Of Utah · R01 · FY2018 · AI